Idiosyncratic drug hepatotoxicity
The DOI matches its Crossref record; 154 of the 155 references it cites were found in a registry or an index.
Abstract
The occurrence of idiosyncratic drug hepatotoxicity is a major problem in all phases of clinical drug development and the most frequent cause of post-marketing warnings and withdrawals. This review examines the clinical signatures of this problem, signals predictive of its occurrence (particularly of more frequent, reversible, low-grade injury) and the role of monitoring in prevention by examining several recent examples (for example, troglitazone). In addition, the failure of preclinical toxicology to predict idiosyncratic reactions, and what can be done to improve this problem, is discussed. Finally, our current understanding of the pathophysiology of experimental drug hepatotoxicity is examined, focusing on acetaminophen, particularly with respect to the role of the innate immune system and control of cell-death pathways, which might provide targets for exploration and identification of risk factors and mechanisms in humans.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The current drug development process suffers from a high failure rate during clinical trials, which is partly due to inadequacy of animal models to accurately predict the toxic side-effects of drugs in humans [1,2].”
From A liver-on-a-chip platform with bioprinted hepatic spheroids (2016) · cites this paper as [2]
In the citing paper
“Drug-induced liver injury (DILI) is a common adverse drug reaction (ADR), and it can lead to liver failure and even death.[1][2][3]”
From Incidence and Etiology of Drug-Induced Liver Injury in Mainland China (2019) · cites this paper as [1]
Citations
Cites
A method for estimating the probability of adverse drug reactions
Naranjo, C. A., Busto, U., Sellers, E. M., Sandor, P., Ruiz, I., Roberts, E. A., Janecek, E., Domecq, C., & Greenblatt, D. J. (1981) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1981.154 · Cited by 11,914
Tolerance, Danger, and the Extended Family
Matzinger, P. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.005015 · Cited by 4,820
Schwartz, G. G. (2001) · JAMA · doi:10.1001/jama.285.13.1711 · Cited by 2,499
Ostapowicz, G., Fontana, R. J., Schiødt, F. V., Larson, A., Davern, T. J., Han, S. H. B., McCashland, T. M., Shakil, A. O., Hay, J. E., Hynan, L., et al. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-12-200212170-00007 · Cited by 2,227
Concordance of the toxicity of pharmaceuticals in humans and in animals
Olson, H., Betton, G., Robinson, D., Thomas, K., Monro, A., Kolaja, G., Lilly, P., Sanders, J., Sipes, G., Bracken, W., et al. (2000) · Regulatory Toxicology and Pharmacology · doi:10.1006/rtph.2000.1399 · Cited by 2,050
Danan, G., & Benichou, C. (1993) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(93)90101-6 · Cited by 1,481
ACETAMINOPHEN-INDUCED HEPATIC NECROSIS. II. ROLE OF COVALENT BINDING IN VIVO
Jollow, D. J., Mitchell, J. R., Potter, W. Z., Davis, D. C., Gillette, J. R., & Brodie, B. B. (1973) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)29664-1 · Cited by 1,204
Acetaminophen-induced Hepatic Necrosis
Jollow, D. J., Thorgeirsson, S. S., Potter, W. Z., Hashimoto, M., & Mitchell, J. R. (1974) · Pharmacology · doi:10.1159/000136547 · Cited by 1,092
ANDRADE, R., LUCENA, M., FERNANDEZ, M., PELAEZ, G., PACHKORIA, K., GARCIARUIZ, E., GARCIAMUNOZ, B., GONZALEZGRANDE, R., PIZARRO, A., & DURAN, J. (2005) · Gastroenterology · doi:10.1016/j.gastro.2005.05.006 · Cited by 856
Hepatotoxic Effects of Tacrine Administration in Patients With Alzheimer's Disease
Watkins, P. B. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03510370044030 · Cited by 829
Research works printed but not linked: 3
- Nelson, S. D. & Bruschi, S. A. in Drug-Induced Liver Disease (eds Kaplowitz, N. & DeLeve, L.) 287–325 (Marcel Dekker, New York, 2003).
- Chien, J. Y., Thummel, K. E. & Slattery, J. T. Pharmakinetic consequence of induction of CYP2E1 by ligand stabilization. Drug Metab. Dispos. 25, 1165–1175 (1997).
- Liu, Z. -X. & Kaplowitz, N. in Clinics in Liver Disease 6, 467–486 (Elsevier, 2002).
Cited by
Items 701–800 of 999
Kuribayashi, S., Uno, Y., Naito, S., & Yamazaki, H. (2011) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2011.00823.x · Cited by 7
Statins: Hepatic Disease and Hepatotoxicity Risk
Cueto-Galán, R., Valdivielso, P., Lucena, M. I., García-Arias, C., Andrade, R. J., & González‐Santos, P. (2008) · The Open Gastroenterology Journal · doi:10.2174/1874259900802010018 · Cited by 9
Mizuno, K., Takeuchi, K., Umehara, K., & Nakajima, M. (2019) · Drug Metabolism and Disposition · doi:10.1124/dmd.119.086546 · Cited by 7
Cao, M., Wang, L., Zhang, L., & Duan, J. (2021) · Science Progress · doi:10.1177/00368504211000535 · Cited by 7
Ameliorative effect of 10-gingerol on drug induced hepatotoxicity in albino rats
Alqasoumi, S. I. (2012) · Journal of Medicinal Plants Research · doi:10.5897/jmpr11.835 · Cited by 7
Buesch, S., Schroeder, J., Bunger, M. K., D’Souza, T., & Stosik, M. (2018) · Applied In Vitro Toxicology · doi:10.1089/aivt.2018.0009 · Cited by 8
Hepatitis tóxica por Camellia sinensis
de Paula, J. M. P., Barquero, J. G., & Hidalgo, S. F. (2008) · Gastroenterología y Hepatología · doi:10.1157/13123613 · Cited by 7
Essential Concepts in Toxicogenomics
Mendrick, D. L. (2008) · Methods in molecular biology · doi:10.1007/978-1-60327-048-9 · Cited by 7
Drug-induced liver injury: Is it time for genetics to change our clinical practice?
Invernizzi, P. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.08.002 · Cited by 8
Molecular docking to investigate HLA-associated idiosyncratic drug reactions
Li, K., Lauschke, V. M., & Zhou, Y. (2025) · Drug Metabolism Reviews · doi:10.1080/03602532.2025.2453521 · Cited by 7
Negi, C. K., Sakolish, C., Tsai, H.-H. D., Nitsche, K. S., Gang, H., Bajaj, P., Ferguson, S., Stanko, J. P., Hewitt, P. G., Kukla, D. A., et al. (2025) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.5c00554 · Cited by 7
Role of oxidative stress and endoplasmic reticulum stress in drug-induced liver injury
Wu, H., Bao, X., Gutierrez, A. H., Nevzorova, Y. A., & Cubero, F. J. (2023) · Exploration of Digestive Diseases · doi:10.37349/edd.2023.00020 · Cited by 8
Alhazzani, K., Alrewily, S. Q., Aljerian, K., Alhosaini, K. A., Algahtani, M., Almutery, M. F., Alhamed, A. S., Nadeem, A., Alotaibi, M. R., & Alanazi, A. Z. (2023) · Human & Experimental Toxicology · doi:10.1177/09603271231188492 · Cited by 6
Zhao, B., Ye, J., Zhao, W., Liu, X., Lan, H., Sun, J., Chen, J., Cai, X., Wei, Q., Zhou, Q., et al. (2024) · Research · doi:10.34133/research.0524 · Cited by 6
Influence of Sex in the Development of Liver Diseases
Zhang, J., Zhang, N., Lyu, Y., & Zhang, X. (2025) · Seminars in Liver Disease · doi:10.1055/a-2516-0261 · Cited by 7
Choi, Y.-J., Kim, H., Kim, J., Song, C.-W., Kim, D., Yoon, S., & Park, H. (2017) · Stem Cell Reviews and Reports · doi:10.1007/s12015-017-9795-4 · Cited by 6
Venetoclax dose adjustment due to drug-drug interactions: a case report and literature review
Fan, W., Guo, J., Zhang, Y., Zhang, R., & Lin, B. (2023) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000001541 · Cited by 8
An activated photoacoustic probe for visualization of CO during drug-induced liver injury and repair
Tan, D., Xu, L., Wang, X., & Lin, W. (2024) · Microchemical Journal · doi:10.1016/j.microc.2024.110060 · Cited by 6
Clinical Considerations of Drug-Induced Hepatotoxicity
Jain, S., & Kaplowitz, N. (2010) · Elsevier eBooks · doi:10.1016/b978-0-08-046884-6.01014-9 · Cited by 8
Self-citationAn Approach to Identifying Preclinical Biomarkers of Susceptibility to Drug-Induced Toxicity
Lin, W., & Chen, J. J. (2011) · Pharmacogenomics · doi:10.2217/pgs.10.204 · Cited by 6
[Case reports of drug-induced liver injury in a reference hospital of Zulia state, Venezuela].
Mengual-Moreno, E., Lizarzábal-García, M., Ruiz-Soler, M., Silva-Suarez, N., Andrade, R. J., Lucena-González, M., Bessone, F., Hernández, N., Sánchez, A., & Medina‐Cáliz, I. (2015) · PubMed · Cited by 7
Brigo, A., & Muster, W. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-409547-2.12321-2 · Cited by 6
Engineered Human Liver Cocultures for Investigating Drug-Induced Liver Injury
Monckton, C. P., & Khetani, S. R. (2018) · Methods in pharmacology and toxicology · doi:10.1007/978-1-4939-7677-5_11 · Cited by 6
Clinical Considerations of Drug-Induced Hepatotoxicity
Motamedi, N., Kaplowitz, N., & Dara, L. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.95665-4 · Cited by 6
Self-citationBiomarkers of drug-induced adverse events
Mendrick, D. L., & Daniels, K. K. (2008) · Expert Review of Clinical Pharmacology · doi:10.1586/17512433.1.1.81 · Cited by 6
Reexposición en hepatotoxicidad: ¿prueba de concepto o accidente terapéutico?
Andrade, R. J., Robles, M., Ortiz, N., & Lucena, M. I. (2008) · Revista Española de Enfermedades Digestivas · doi:10.4321/s1130-01082008000500001 · Cited by 7
Zou, W., Roth, R. A., & Ganey, P. E. (2012) · Wiley eBooks · doi:10.1002/9780470921920.edm088 · Cited by 6
Clinical Chemistry in Toxicity Testing: Scope and Methods
Gosselin, S., Ramaiah, L., & Earl, L. K. (2009) · Wiley eBooks · doi:10.1002/9780470744307.gat040 · Cited by 7
Prevention and Management of Side‐effects of Antiepileptic Drugs
Zaccara, G., & Perucca, P. (2015) · Wiley eBooks · doi:10.1002/9781118936979.ch20 · Cited by 6
Light, D. S., Aleo, M. D., & Kenna, J. G. (2018) · Methods in pharmacology and toxicology · doi:10.1007/978-1-4939-7677-5_17 · Cited by 6
The role of exosomal lncRNAs in acetaminophen-induced induced liver injury in SD rats
Yang, Z., Shi, L., Zheng, M., Hou, M., Zhou, M., Su, N., Lang, H., Zhao, L., Gu, M., Tang, N., et al. (2024) · Non-coding RNA Research · doi:10.1016/j.ncrna.2024.05.011 · Cited by 5
Lumiracoxib metabolism in male C57bl/6J mice: characterisation of novelin vivometabolites
Dickie, A. P., Wilson, C. E., Schreiter, K., Wehr, R., Wilson, I. D., & Riley, R. J. (2016) · Xenobiotica · doi:10.1080/00498254.2016.1206239 · Cited by 5
Role of the Adaptive Immune System in Idiosyncratic Drug-Induced Liver Injury
Uetrecht, J. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-387817-5.00011-x · Cited by 8
Park, M. S., Kim, J., Park, I., Lee, H.-K., Kim, C., Jo, C., Kim, Y.-K., Min, B.-H., Ryoo, J., Lee, D.-S., et al. (2015) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2015.08.017 · Cited by 5
The evaluation of drug rechallenge: The casopitant Phase III program
Hunt, C. M., Papay, J. I., Rich, D. S., Abissi, C. J., & Russo, M. W. (2010) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2010.09.014 · Cited by 5
Evidence-Based Liver Chemistry Monitoring in Drug Development
Hunt, C. M., Forster, J. K., Papay, J. I., & Stirnadel-Farrant, H. A. (2009) · Pharmaceutical Medicine · doi:10.1007/bf03256763 · Cited by 5
Kaur, G. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814655-2.00014-1 · Cited by 5
Zhou, Z., Zhou, H., Zhang, K., Wang, Y., Gao, Y., Liu, F., Yang, H., & Yang, S. (2021) · Dyes and Pigments · doi:10.1016/j.dyepig.2021.109586 · Cited by 5
In Silico Models for Hepatotoxicity
Ellison, C. M., Hewitt, M., & Przybylak, K. R. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-1960-5_14 · Cited by 8
Hassan-Kadle, M. A., & Мазурчик, Н. В. (2016) · Open Journal of Gastroenterology · doi:10.4236/ojgas.2016.65019 · Cited by 5
Kiyosawa, N., & Manabe, S. (2016) · The Journal of Toxicological Sciences · doi:10.2131/jts.41.sp15 · Cited by 5
Requirements for designing organ-on-a-chip platforms to model the pathogenesis of liver disease
Ishida, S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-817202-5.00005-x · Cited by 6
Hara, T., Ohara, T., Taniguchi, M., Sakai, H., Oka, K., Iwai, N., Tsuji, T., Okuda, T., Nagata, A., Komaki, T., et al. (2021) · Internal Medicine · doi:10.2169/internalmedicine.6664-20 · Cited by 5
Drug-induced hepatotoxicity: application of mass spectrometry based metabonomics
Dahab, A. A., & Smith, N. W. (2012) · Analytical Methods · doi:10.1039/c2ay25413a · Cited by 8
Miyaji, Y., Makino, C., Kurihara, A., Suzuki, W., & Okazaki, O. (2012) · Bioanalysis · doi:10.4155/bio.11.316 · Cited by 5
A case of repeated liver injury induced by different herbal medicines containing the same components
Maruyama, Y., Yoshizawa, K., Tsuruta, F., Maruyama, M., Fujimori, K., Shigeno, T., Fukushima, M., Uehara, T., Morita, S., Joshita, S., et al. (2014) · Kanzo · doi:10.2957/kanzo.55.214 · Cited by 5
Detection, Elimination, Mitigation, and Prediction of Drug-Induced Liver Injury in Drug Discovery
Pognan, F. (2018) · Methods in pharmacology and toxicology · doi:10.1007/978-1-4939-7677-5_2 · Cited by 6
Apica, B. S., & Lee, W. M. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-386456-7.04208-8 · Cited by 5
Current and Future Challenges for Collaborative Computational Technologies for the Life Sciences
Williams, A. J., Arnold, R. J. G., Neylon, C., Spencer, R. W., Schürer, S. C., & Ekins, S. (2011) · Wiley eBooks · doi:10.1002/9781118026038.ch28 · Cited by 7
DRUG AND ALCOHOL INDUCED HEPATOTOXICITY
Butura, A. (2008) · Figshare · Cited by 12
Animal Models of Disease for Future Toxicity Predictions
Morgan, S. J., & Elangbam, C. S. (2016) · Wiley eBooks · doi:10.1002/9781119053248.ch18 · Cited by 8
Fontana, R. J., & Bari, K. (2017) · Wiley eBooks · doi:10.1002/9781119251316.ch17 · Cited by 6
Drug‐Induced Hepatotoxicity: Advances in Preclinical Predictive Strategies and Tools
Dambach, D. M. (2014) · Predictive ADMET · doi:10.1002/9781118783344.ch19 · Cited by 4
Zhao, Y., Jin, T., Xu, T., Fang, Y., Zheng, Q., Luo, W., Zhu, W., Chen, Y., Wang, J., Chen, Y., et al. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.06.027 · Cited by 4
de Bruijn, V. M. P., & Rietjens, I. M. C. M. (2024) · Archives of Toxicology · doi:10.1007/s00204-024-03775-6 · Cited by 4
Avaliação da toxicidade aguda e subcrônica do extrato etanólico de Luehea divaricata
da Trindade, H. I. (2023) · Seven Editora eBooks · doi:10.56238/sevenediefatiamodelodenoqt-003 · Cited by 3
Ogese, M. O., Lister, A., Farrell, L., Gardner, J., Kafu, L., Ali, S.-E., Gibson, A., Hillegas, A., Meng, X., Pirmohamed, M., et al. (2023) · Toxicological Sciences · doi:10.1093/toxsci/kfad101 · Cited by 4
The application and significance of 3D printing technology in biomedicine
Yu, J. (2024) · Applied and Computational Engineering · doi:10.54254/2755-2721/58/20240724 · Cited by 4
Tsaioun, K., & Kates, S. A. (2012) · Springer eBooks · doi:10.1007/978-1-4419-9530-8_30 · Cited by 6
Advances in the development and use of human tissue-based techniques for drug toxicity testing
Clotworthy, M., & Archibald, K. (2013) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2013.802770 · Cited by 4
Corticosteroid Therapy for Crizotinib-induced, Allergy-mediated Liver Injury: a Case Report
Oonuma, H., Kato, J., Oyama, K., Kawahara, R., Seki, K., & Inoue, Y. (2015) · Haigan · doi:10.2482/haigan.55.48 · Cited by 4
Shimizu, Y., Sasaki, T., Takeshita, J., WATANABE, M., Shizu, R., Hosaka, T., & Yoshinari, K. (2021) · PLoS ONE · doi:10.1371/journal.pone.0253855 · Cited by 5
Daño hepático inducido por medicamentos: relación entre el índice R y la histopatología
Ardila-Suárez, O. M., Oriz-Benjumea, L., Arteta, A. A., & Guevara-Casallas, L. G. (2022) · Revista de Gastroenterología de México · doi:10.1016/j.rgmx.2021.03.008 · Cited by 4
Cao, L., Zhao, H., Qian, M., Shao, C., Zhang, Y., & Yang, J. (2022) · Journal of Biomaterials Science Polymer Edition · doi:10.1080/09205063.2022.2102715 · Cited by 4
Clinical Pathology in Nonclinical Toxicity Studies
Aulbach, A. D., Ennulat, D., & Schultze, A. E. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-85704-8.00008-6 · Cited by 8
HLA Polymorphisms And TKI-Induced Liver Injury in Patients with Cancer: A Meta-analysis
Xiang, Q., Zhang, Z., Wu, Y., Zuo, S., Liu, Q., Liu, T., Wang, X., & Cui, Y. (2019) · Journal of Cancer · doi:10.7150/jca.26727 · Cited by 4
BML-257, a Small Molecule that Protects against Drug-Induced Liver Injury in Zebrafish
Jagtap, U., Basu, S., Lokhande, L., Bharti, N., & Sachidanandan, C. (2022) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.2c00100 · Cited by 4
Late‐onset acetaminophen‐induced allergic hepatitis with progression to chronicity
Mishima, M., Takahashi, K., Yokode, M., Kimura, Y., Sawai, Y., Ueda, Y., & Chiba, T. (2014) · Hepatology Research · doi:10.1111/hepr.12399 · Cited by 4
Kodell, R. L., & Chen, J. J. (2010) · Personalized Medicine · doi:10.2217/pme.10.7 · Cited by 4
Identification of drug-induced toxicity biomarkers for treatment determination
Lu, T., & Chen, J. J. (2015) · Pharmaceutical Statistics · doi:10.1002/pst.1684 · Cited by 4
Immune Mechanisms in Drug-Induced Hepatotoxicity
Liu, Z., & Kaplowitz, N. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-518-3_29 · Cited by 5
Self-citationKwast, L. M., Fiechter, D., Kruijssen, L. J. W., Bleumink, R., Ludwig, I. S., Bol‐Schoenmakers, M., Smit, J. J., & Pieters, R. H. H. (2016) · Journal of Immunotoxicology · doi:10.3109/1547691x.2016.1139643 · Cited by 5
Drug-Induced Liver Injury: Mechanism-Informed Prediction in Drug Development
Goldring, C. E., Weaver, R. J., Kramer, B. A., Klingmüller, U., Oppelt, A.-S., der Water, B. V., Commandeur, J. N. M., Guillouzo, A., Naisbitt, D. J., French, N. S., et al. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-409547-2.12384-4 · Cited by 5
Gad, S. C. (2010) · Pharmaceutical Sciences Encyclopedia · doi:10.1002/9780470571224.pse076 · Cited by 4
In VitroMetabolism in Preclinical Drug Development
Pelkonen, O., Tolonen, A., Turpeinen, M., & Uusitalo, J. (2010) · Wiley eBooks · doi:10.1002/9780470571224.pse051 · Cited by 4
Development of a complex 3D in vitro alternative model to evaluate the safety of advanced materials
Tutty, M. A., Simone, T., & Prina‐Mello, A. (2025) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2025.117520 · Cited by 3
Nitsche, K. S., Sakolish, C., Carmichael, P. L., Hewitt, P. G., Bajaj, P., Ferguson, S., Lloyd, S. M., Wilson, S. S., Bouwmeester, H., & Rusyn, I. (2025) · Archives of Toxicology · doi:10.1007/s00204-025-04263-1 · Cited by 6
Development of a CYP2D6-enhanced HepaRG cell model with improved CYP2D6 metabolic capacity
Obara, C., Iizaka, Y., Mine, A., Anzai, Y., Tada, M., & Yamaguchi, S. (2025) · PLoS ONE · doi:10.1371/journal.pone.0339559 · Cited by 3
Drug-induced liver injury secondary to tirzepatide
Cao, C., Subhaharan, D., Mikhail-Gouda, P., & Haig, A. (2026) · BMJ Case Reports · doi:10.1136/bcr-2025-269172 · Cited by 4
Advanced human liver models for the assessment of drug-induced liver injury
Mun, S. J., Lee, J., Shin, Y., & Son, M. J. (2022) · Organoid · doi:10.51335/organoid.2022.2.e17 · Cited by 4
A brief overview of drug-induced liver damage
Roy, S., Shah, Z., & Chakraborthy, G. S. (2024) · The Egyptian Journal of Internal Medicine · doi:10.1186/s43162-024-00315-7 · Cited by 8
Ali, A. S. M., Wu, D., Roehrs, V., Nguyen, D. B. T., Ziersch, M., Braeuning, A., & Kurreck, J. (2025) · Biofabrication · doi:10.1088/1758-5090/ae1063 · Cited by 6
Drug-induced liver injury secondary to anabolic steroid use
Díaz-García, J. D., Córdova‐Gallardo, J., Torres-Viloria, A., Estrada-Hernández, R., & Torre-Delgadillo, A. (2019) · Revista de Gastroenterología de México (English Edition) · doi:10.1016/j.rgmxen.2019.01.007 · Cited by 3
Il était une fois l’hépatotoxicité…
Daré, B. L., Ferron, P., & Gicquel, T. (2021) · médecine/sciences · doi:10.1051/medsci/2021009 · Cited by 4
Lesiński, W., Mnich, K., & Rudnicki, W. R. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.661075 · Cited by 3
Drug-induced liver injury: Relation between the R ratio and histopathology
Ardila-Suárez, O. M., Oriz-Benjumea, L., Arteta, A. A., & Guevara-Casallas, L. G. (2022) · Revista de Gastroenterología de México (English Edition) · doi:10.1016/j.rgmxen.2022.03.006 · Cited by 3
Zhang, H., Zhang, H.-R., Hu, M., & Qi, H.-Z. (2022) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2022.107185 · Cited by 4
Boussaha, S., Lassed, S., Abdelwahab, A. B., Krid, A., Altun, M., Chalard, P., Chalchat, J., Figuérédo, G., Zama, D., Demirtaş, İ., et al. (2023) · Chemistry & Biodiversity · doi:10.1002/cbdv.202301535 · Cited by 4
Connecting biotransformation with toxicity
Kaur, S., Tekade, M., Pawar, B., Vasdev, N., Gupta, T., Sreeharsha, N., & Tekade, R. K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15842-1.00021-1 · Cited by 3
Liver Injury Due to Drugs and Herbal Agents
Kleiner, D. E. (2011) · Elsevier eBooks · doi:10.1016/b978-0-443-06803-4.00024-1 · Cited by 3
Bioprinting of Biomimetic Tissue Models for Disease Modeling and Drug Screening
Tang, M., Berry, D. B., Miller, K. L., Ma, X., & Chen, S. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-824552-1.00002-5 · Cited by 6
Binaprofen induces zebrafish liver injury via the mitochondrial pathway
Guo, Q., Chen, G., Ou, H., Ruo-min, J., Ni, Q., & Qin, R. (2022) · Molecular Medicine Reports · doi:10.3892/mmr.2022.12830 · Cited by 3
Pohjala, L., Hakkola, J., & Vuorela, P. M. (2007) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2008.11.003 · Cited by 4
Acetaminophen-Induced Forestomach Lesion in Normal Rats Following Intravenous Exposure
McKee, J. S., & Gass, J. H. (2011) · Toxicologic Pathology · doi:10.1177/0192623311413789 · Cited by 3
Zhang, M., Resuello, C. M., Guo, J. X., Powell, M. E., Elmore, C. S., Hu, J., & Vishwanathan, K. (2013) · Drug Metabolism and Disposition · doi:10.1124/dmd.112.050450 · Cited by 3
Cellular imaging: a key phenotypic screening strategy for predictive toxicology
Xu, J. J. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00191 · Cited by 3
Clinical Manifestations and Management of Drug-Induced Liver Diseases
Maddrey, W. C. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-387817-5.00014-5 · Cited by 5
Hepatotoxicity of Antiviral Agents
Núñez, M. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-387817-5.00028-5 · Cited by 3
A CLINICAL APPROACH TO DRUG-INDUCED LIVER INJURY
Blockman, M., & Cohen, K. (2015) · Cited by 3
Tang, N., Liu, J., Chen, B., Zhang, Y., Yu, M., Cai, Z., & Chen, H. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.6295 · Cited by 4
Metadata
- Authors
- Kaplowitz, N.
- Affiliations
- University of Southern California (US)
- Corresponding author
- Kaplowitz, Neil
- ORCID
- Kaplowitz, Neil
- Venue
- Nature Reviews Drug Discovery
- Published
- 2005-06
- Volume
- 4
- Issue
- 6
- Pages
- 489-499
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2017783406
- Cited by
- 1,054
- References
- 155
- Citations by year
- 2026: 29 · 2025: 35 · 2024: 35 · 2023: 44 · 2022: 31 · 2021: 49 · 2020: 45 · 2019: 48 · 2018: 54 · 2017: 66 · 2016: 72 · 2015: 55 · 2014: 64 · 2013: 57 · 2012: 52
- FWCI
- 5.66
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Health Sciences › Medicine › Pharmacology (medical) › Drug-Induced Adverse Reactions
- Keywords
- drug-induced liver injury, troglitazone, preclinical toxicology, hepatotoxicity prediction, pharmacovigilance, acetaminophen hepatotoxicity, innate immune system, cell death pathways, drug withdrawal, post-marketing surveillance
- MeSH terms
- Animals, Pharmaceutical Preparations, Humans, Liver, Liver Diseases, Chemical and Drug Induced Liver Injury, Drug-Related Side Effects and Adverse Reactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.